BA
GILD icon

Bristol Advisors’s Gilead Sciences GILD Stock Holding History

Bristol Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-18,000
Closed -$1.13M – 52
2018
Q4 		$1.13M Buy
+18,000
New +$1.26M 1.35% 12
2018
Q2 		– Sell
-14,800
Closed -$1.12M – 69
2018
Q1 		$1.12M Sell
14,800
-22,600
-60% -$1.8M 3.64% 9
2017
Q4 		$2.68M Buy
37,400
+21,400
+134% +$1.63M 1.68% 15
2017
Q3 		$1.3M Buy
+16,000
New +$1.22M 1.31% 18

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bristol Advisors's GILD Position: Q1 2019 in Review

Bristol Advisors sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 18,000 shares — an estimated $1.13M sold.

Bristol Advisors first reported a position in GILD in Q3 2017 and held it in 4 quarters. The position peaked at $2.68M in Q4 2017. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

  • Bristol Advisors reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
  • Bristol Advisors sold 18,000 Gilead Sciences shares in Q1 2019, an estimated $1.13M.
  • Bristol Advisors first reported a position in Gilead Sciences in Q3 2017 and held it in 4 quarters.
  • Bristol Advisors's Gilead Sciences position peaked at $2.68M in Q4 2017.
  • 1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Bristol Advisors's 13F filing for Q1 2019, filed 29 Apr 2019.